{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nalidixic root_polymer_monomers_monomerSubstance_refPname in Monomer Substance Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
ANDA211546
(2001)
Source URL:
First approved in 2001
Source:
ANDA211546
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M020
(2001)
Source URL:
First approved in 2001
Source:
M020
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA091695
(2000)
Source URL:
First approved in 2000
Source:
ANDA091695
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1998
Source:
NDA020838
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333
(2010)
Source URL:
First approved in 1998
Source:
NDA020901
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA020637
(1996)
Source URL:
First approved in 1996
Source:
NDA020637
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1996
Source:
NDA021753
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA020612
(1999)
Source URL:
First approved in 1995
Source:
ANDA200816
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Medipap Cool by Cho-A Pharm.Co.,Ltd.
(2018)
Source URL:
First approved in 1995
Source:
ANDA076873
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Typhim Vi by Sanofi Pasteur Limited [Canada]
Source URL:
First approved in 1994
Source:
BLA103936
Source URL:
Class:
POLYMER
